IMPACT OF EU HTA REGULATION ON RARE DISEASES AND ORPHAN DRUGS
<> Date: 7 October 2022 | 09:00 – 17:00 (Eastern European Time – Sofia, Bulgaria)
<> Topic: IMPACT OF EU HTA REGULATION ON RARE DISEASES AND ORPHAN DRUGS
<> Format: hybrid event (in-person in Sofia (Bulgaria) and online streaming)
<> Summary: The central topic of this event is the recently adopted EU Regulation on HTA and its impact on rare diseases and orphan drugs. This document is considered a key milestone to all rare diseases and orphan drugs stakeholders in Europe, as this is largely meant to improve access to innovative treatments. The regulation is expected to strengthen the quality of HTA across the EU and ensure the long-term sustainability of EU HTA cooperation.
The 9th International Symposium on HTA aims to be a platform for representatives of health authorities, patient organizations, industry and European reference networks for rare diseases to share best practices and foster collaboration in light of the upcoming implementation of the EU Regulation.
<> Language: The symposium will be held in English.
<> Access and registration:
– On site attendance in Sofia (Bulgaria): By personal invitation from the Organizing committee
– Virtual attendance (academic, health authorities, patient groups representatives): Please, register by completing the short form bellow. The organizing committee will send detailed instructions how to connect and participate online in the event.
– Industry representatives: Please, contact the Organizing committee at firstname.lastname@example.org
This event is jointly organized by the Institute for Rare Diseases (IRD) – Bulgaria and the International Conference on Rare Diseases and Orphan Drugs (ICORD)